Françoise Stanke-Labesque Selected Research

Françoise Stanke-Labesque Research Topics

Disease

12	Inflammation (Inflammations) 07/2021 - 06/2008
7	Atherosclerosis 01/2018 - 09/2012
6	Obstructive Sleep Apnea 01/2018 - 08/2009
5	Obesity 12/2019 - 08/2009
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 01/2004
5	Hypoxia (Hypoxemia) 01/2018 - 08/2009
4	Hypertension (High Blood Pressure) 01/2006 - 02/2003
3	Insulin Resistance 12/2019 - 01/2014
3	Chronic Hepatitis C 05/2011 - 01/2003
2	Poisoning 01/2022 - 04/2015
2	Wounds and Injuries (Trauma) 07/2021 - 12/2018
2	Abdominal Obesity 12/2019 - 01/2014
2	Vascular Diseases (Vascular Disease) 01/2018 - 03/2002
2	Immune System Diseases (Immune Disorders) 05/2010 - 05/2010
2	Systemic Scleroderma (Systemic Sclerosis) 01/2005 - 05/2002
1	Coma (Comas) 01/2022
1	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 01/2022
1	Rheumatoid Arthritis 12/2021
1	Ischemia 12/2021
1	COVID-19 07/2021
1	Infections 07/2021
1	Aspergillosis 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2019
1	Dyslipidemias (Dyslipidemia) 12/2019
1	Crohn Disease (Crohn's Disease) 08/2019
1	Cerebral Hemorrhage 12/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Carotid Artery Diseases 01/2014

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2022 - 01/2004
6	LeukotrienesIBA 01/2018 - 09/2003
5	Voriconazole (Vfend)FDA LinkGeneric 05/2021 - 08/2017
3	cysteinyl-leukotrieneIBA 01/2018 - 06/2008
3	ApolipoproteinsIBA 01/2018 - 08/2013
3	Ribavirin (Virazole)FDA LinkGeneric 05/2011 - 01/2003
3	Azathioprine (Imuran)FDA LinkGeneric 05/2010 - 01/2004
3	8-epi-prostaglandin F2alphaIBA 06/2005 - 03/2002
2	Monoclonal AntibodiesIBA 12/2021 - 08/2019
2	EnzymesIBA 07/2021 - 11/2020
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2021 - 03/2021
2	CytokinesIBA 03/2021 - 01/2016
2	Cytochrome P-450 CYP3AIBA 03/2021 - 08/2017
2	Cytochrome P-450 CYP2C19IBA 03/2021 - 08/2017
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2014
2	Apolipoproteins E (ApoE)IBA 01/2018 - 10/2014
2	Messenger RNA (mRNA)IBA 01/2018 - 08/2013
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2015 - 08/2013
2	LipidsIBA 02/2014 - 01/2014
2	Interferon-alpha (Interferon Alfa)IBA 05/2011 - 05/2011
2	Thioguanine (Tioguanine)FDA Link 05/2010 - 05/2010
2	TransferasesIBA 05/2010 - 05/2010
2	6-thioguanylic acidIBA 05/2010 - 05/2010
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 05/2010 - 05/2010
2	2-mercaptopurineIBA 05/2010 - 05/2010
2	Leukotriene E4IBA 08/2009 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 06/2008 - 05/2002
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2022
1	Loxapine (Loxitane)FDA LinkGeneric 01/2022
1	Vancomycin FDA LinkGeneric 01/2022
1	Tiapride HydrochlorideIBA 01/2022
1	cyamemazineIBA 01/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022
1	tocilizumab (atlizumab)FDA Link 12/2021
1	4- (4- (3- adamantan- 1- ylureido)cyclohexyloxy)benzoic acidIBA 12/2021
1	Rituximab (Mabthera)FDA Link 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021
1	Drinking WaterIBA 12/2021
1	Blood Proteins (Serum Proteins)IBA 07/2021
1	CytochromesIBA 05/2021
1	C-Reactive ProteinIBA 05/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2019
1	11,15- dioxo- 9- hydroxy- 2,3,4,5- tetranorprostan- 1,20- dioic acidIBA 12/2019
1	ProstaglandinsIBA 12/2019
1	Triglycerides (Triacylglycerol)IBA 12/2019
1	Prostaglandin D2IBA 12/2019
1	Adalimumab (Humira)FDA Link 08/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	TicagrelorIBA 12/2018
1	AntidotesIBA 12/2018
1	Meropenem (Merrem)FDA LinkGeneric 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2018
1	montelukast (Singulair)FDA Link 01/2018
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2018
1	Insulin (Novolin)FDA Link 01/2016
1	Thromboxane A2 (A2, Thromboxane)IBA 09/2015
1	Amitriptyline (Elavil)FDA LinkGeneric 04/2015
1	Docosahexaenoic AcidsIBA 10/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2014
1	Inflammation MediatorsIBA 02/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Atorvastatin (Lipitor)FDA Link 01/2014
1	SC 560IBA 08/2013
1	ThromboxanesIBA 08/2013
1	Leukotriene B4IBA 09/2012

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2014
2	Continuous Positive Airway Pressure 01/2018 - 09/2015
1	Home Nursing (Nursing, Home) 01/2022
1	Hematopoietic Stem Cell Transplantation 08/2017